Eligo Bioscience
Bacterial ecosystems control
Eligo Bioscience has raised €49M across 3 funding rounds from 5 investors, most recently a Grant round in May 2025. Based in France; active in Healthtech. Data as of 4 Nov 2026.
Total raised
€49M
€48,938,843
Funding rounds
3
Investors
5
distinct backers
Active since
2017-09
latest 2025-05
Funding by year
EUR raised per yearEligo Bioscience — funding by year — interactive chart.
Data table
| Eligo Bioscience — funding by year | |
|---|---|
| 2017 | €17M |
| 2023 | €28M |
| 2025 | €4.5M |
Signals
High confidenceRaise-next likelihood26
base rate 45% for Grant
- ▼ Past typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood11
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-05-13 | Grant | €4.5M | French Government | View deal → |
| 2023-12-05 | Series B | €28M | Bpifrance,Khosla Ventures,Sanofi Ventures,Seventure Partners | View deal → |
| 2017-09-19 | Series A | €17M | Khosla Ventures,Seventure Partners | View deal → |